Panagora Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $765K | Buy |
+210,205
| New | +$765K | ﹤0.01% | 689 |
|
|
2022
Q3 | – | Sell |
-250,894
| Closed | -$89K | – | 1430 |
|
|
2022
Q2 | $89K | Hold |
250,894
| – | – | ﹤0.01% | 1444 |
|
|
2022
Q1 | $180K | Buy |
250,894
+233
| +0.1% | +$167 | ﹤0.01% | 1471 |
|
|
2021
Q4 | $566K | Buy |
250,661
+846
| +0.3% | +$1.91K | ﹤0.01% | 1171 |
|
|
2021
Q3 | $719K | Buy |
249,815
+179,229
| +254% | +$516K | ﹤0.01% | 1130 |
|
|
2021
Q2 | $268K | Buy |
+70,586
| New | +$268K | ﹤0.01% | 1568 |
|
|
2020
Q4 | – | Sell |
-30,487
| Closed | -$77K | – | 2800 |
|
|
2020
Q3 | $77K | Buy |
+30,487
| New | +$77K | ﹤0.01% | 1910 |
|
|
2018
Q2 | – | Sell |
-130,574
| Closed | -$1.24M | – | 2367 |
|
|
2018
Q1 | $1.24M | Sell |
130,574
-15,970
| -11% | -$152K | ﹤0.01% | 1078 |
|
|
2017
Q4 | $2.18M | Buy |
146,544
+116,418
| +386% | +$1.73M | 0.01% | 847 |
|
|
2017
Q3 | $593K | Hold |
30,126
| – | – | ﹤0.01% | 1303 |
|
|
2017
Q2 | $433K | Buy |
+30,126
| New | +$433K | ﹤0.01% | 1394 |
|
|
2016
Q1 | – | Sell |
-112,620
| Closed | -$1.46M | – | 2287 |
|
|
2015
Q4 | $1.46M | Sell |
112,620
-16,524
| -13% | -$213K | 0.01% | 922 |
|
|
2015
Q3 | $1.25M | Buy |
129,144
+24,987
| +24% | +$241K | 0.01% | 933 |
|
|
2015
Q2 | $1.07M | Buy |
104,157
+101,284
| +3,525% | +$1.04M | 0.01% | 1065 |
|
|
2015
Q1 | $32K | Buy |
+2,873
| New | +$32K | ﹤0.01% | 2149 |
|